investorscraft@gmail.com

MaxCyte, Inc. (MXCT)

Previous Close
$2.24
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)46.581984
Intrinsic value (DCF)1.23-45
Graham-Dodd Method0.01-100
Graham Formulan/a

Company Information

9713 Key West Avenue
Rockville, MD 20850
United States
Phone: 301 944 1700
Industry: Medical - Devices
Sector: Healthcare
CEO: Mr. Maher Masoud
Full Time Employees: 114

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

HomeMenuAccount